| Product Name | Sitaxsentan | IPI 1040 | TBC-11251 |
|---|---|
| CAS | 184036-34-8 |
| Formula | C18H15ClN2O6S2 |
| MW | 454.90 |
| Storage condition | Store in a dry and dark sealed container, short-term (weeks to months) storage at 0-4 ℃, long-term (months to years) storage at -20 ℃. |
| Size | Availability | Price(USD) | VIP Price (USD) | Quantity | |
|---|---|---|---|---|---|
|
There is no price information at the moment, you can send an inquiry,and we will reply to you as soon as possible. |
|||||
| Product Name | Sitaxsentan | IPI 1040 | TBC-11251 |
|---|---|
| CAS | 184036-34-8 |
| Formula | C18H15ClN2O6S2 |
| MW | 454.90 |
| Storage condition | Store in a dry and dark sealed container, short-term (weeks to months) storage at 0-4 ℃, long-term (months to years) storage at -20 ℃. |
Sitaxsentan (TBC-11251) is A selective endothelin A (ETA) receptor antagonist. Endothelin is an effective vasoconstrictor. Sitaxsentan blocks the binding of endothelin to its receptors, thereby eliminating the harmful effects of endothelin.
PMID: 22079088 DOI: 10.1016/j.pupt.2011.10.002
Sitaxsentan-induced acute severe hepatitis treated with glucocorticoid therapy.
PMID: 22332138 PMCID: PMC3298840 DOI: 10.1155/2012/567024
Effect of transition from sitaxsentan to ambrisentan in pulmonary arterial hypertension.
PMID: 21468170 PMCID: PMC3064451 DOI: 10.2147/VHRM.S15026
PMID: 21451953 DOI: 10.1007/s00508-011-1540-4